food and drug administration

Maharashtra FDA chief Tukaram Mundhe refutes reports of transfer: 'Fight against unsafe food, spurious drugs goes on'

October 12, 2026

Maharashtra Food and Drug Administration (FDA) Commissioner Tukaram Mundhe refuted transfer reports on Monday, asserting that the fight…

MMedication

Will an FDA crackdown curb access to cheaper GLP-1 weight-loss drugs? Here's what to know.

September 24, 2026

The Food and Drug Administration has warned a major compounding pharmacy that it violated federal law by making…

MMedication

Crushing drugs can reduce efficacy, worsen side effects, say pharmacists

September 20, 2026

Crushing modified-release tablets can cause medicines designed to be released gradually to enter the body too quickly, exposing…

MMedication

U.S. FDA Accepts Teva’s New Drug Application (NDA) and Grants Priority Review for Ecopipam, a First-in-Class Investigational Therapy for Pediatric Patients with Tourette Syndrome

August 19, 2026

Teva Pharmaceutical Industries Ltd Ecopipam (EBS-101) is a first-in-class selective D1 (dopamine) receptor antagonist with Orphan Drug designation NDA…

MMedication

FDA says recalled blood thinner sold across the US is unlikely to cause serious harm

August 11, 2026

A recalled generic blood thinner has drawn national attention. But the U.S. Food and Drug Administration says the…

MMedication

Blood Pressure Drug Recalled Nationwide, FDA Announces

August 11, 2026

When a prescription drug is recalled, often it’s a generic version that’s being pulled from market. But this…

MMental health

Major VA study to examine effectiveness of psilocybin on depression, PTSD

August 6, 2026

The Department of Veterans Affairs is launching research to determine whether psilocybin — the psychoactive ingredient in “magic…

MMedication

Antihistamine Recall: 34,000 Bottles at Highest Risk Level

August 6, 2026

It’s not the first recall we’ve seen for antihistamine, but it might be one of the first with…

MMedication

FDA Approves Mannkind's At-Home Treatment Option for Heart Failure or Kidney Disease

July 28, 2026

Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. Mannkind…

MMedication

Two pain drugs used by millions will be combined in a single tablet

July 25, 2026

Consumers will soon have a new over-the-counter pain relief option that combines Tylenol with naproxen, an anti-inflammatory medication.…

NNutrition

Popular Supplement Recalled Due to Salmonella Risk: Nausea and Bloody Diarrhea Possible

July 23, 2026

Your morning supplement could make you sick. The U.S. Food and Drug Administration (FDA) announced that Moringa Leaf…

MMedication

FDA Updates Nationwide Blood Pressure Drug Recall

July 23, 2026

Recent blood pressure medication recalls have occurred repeatedly for issues with how they dissolve, as the chemical composition…

Maharashtra FDA chief Tukaram Mundhe refutes reports of transfer: ‘Fight against unsafe food, spurious drugs goes on’

Will an FDA crackdown curb access to cheaper GLP-1 weight-loss drugs? Here’s what to know.

Crushing drugs can reduce efficacy, worsen side effects

U.S. FDA Accepts Teva’s New Drug Application (NDA) and Grants Priority Review for Ecopipam, a First-in-Class Investigational Therapy for Pediatric Patients with Tourette Syndrome

FDA says recalled blood thinner sold across the US is unlikely to cause serious harm

Blood Pressure Drug Recalled Nationwide, FDA Announces

Major VA study to examine effectiveness of psilocybin on depression, PTSD

Antihistamine Recall: 34,000 Bottles at Highest Risk Level

FDA Approves Mannkind’s At-Home Treatment Option for Heart Failure or Kidney Disease

Two pain drugs used by millions will be combined in a single tablet

Popular Supplement Recalled Due to Salmonella Risk: Nausea and Bloody Diarrhea Possible

FDA Updates Nationwide Blood Pressure Drug Recall